NCT03324984View on ClinicalTrials.gov

1% Chloroprocaine(PF) vs. Bupivacaine Spinals

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Return of Motor and Sensory BlockadeAnesthesia, SpinalDecrease Discharge Time Status Post Hemorrhoidectomy
Interventions
DRUG

1% chloroprocaine

In 2018, 1% Chloroprocaine was approved by the FDA for spinal anesthesia use.

DRUG

0.75% bupivacaine

Bupivacaine is used on label

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03324984 - 1% Chloroprocaine(PF) vs. Bupivacaine Spinals | Biotech Hunter | Biotech Hunter